Converging evidence suggest that levels of alpha-Synuclein (aSyn) expression play a critical role in Parkinson's disease (PD). Several mutations of the SNCA gene, encoding for aSyn have been associated to either the familial or the sporadic forms of PD. Nonetheless, the mechanism underlying wild type aSyn-mediated neurotoxicity in neuronal cells as well as its specific driving role in PD pathogenesis has yet to be fully clarified. In this view, the development of proper in vitro cellular systems is a crucial step.
Introduction
Lewy bodies (LBs) are considered a capital hallmark of Parkinson's Disease (PD). They consist of cytoplasmatic inclusions mainly composed of fibrillar misfolded α-synuclein (aSyn) aggregates within the brain parenchyma [1] . aSyn is a small 140-residue protein highly abundant in neurons and particularly localised at the presynaptic terminals, where it is thought to play roles in vesicles trafficking and in the assembling of the SNARE-complex for neurotransmitters release [2] . Mutations of the SNCA gene, encoding for aSyn, are either associated to rare familial PD or represent risk factors for sporadic PD [3, 4] . Furthermore, increased SCNA copy number variation has been shown to be causal for PD, thus suggesting that increased aSyn protein levels are sufficient to trigger the disease [5] . In PD patients, aggregation of aSyn in LBs has been shown, resulting in its mislocalization and loss of function, ultimately leading to the loss of dopaminergic neurons. Beside its role in mature neurons, in vivo aSyn overexpression has been shown to affect proliferative potential of mouse hippocampal NSCs, resulting in a reduction of the pool of neural progenitors and decreased neuronal differentiation and maturation [6] [7] [8] [9] . Also, ectopic expression of aSyn was shown to affect the migration of NSCs in mouse subventricular zone [10] .
Despite the association to PD has been known for decades, aSyn function in human Neural Stem cells (hNSCs) and neurons as well as its involvement in PD is still poor understood.
So far, the main limitations have been due to the inaccessibility of adequate in vitro cellular models. Indeed, most of the studies aimed at defining a clear role for aSyn in normal and PD neurons have been so far carried out using either non-human systems, including rodents culture [6, 7, 10] , non-neuronal transformed cell lines [11] or non CNS-derived neuronal-like cells [12, 13] .
More recently, the advent of hiPSCs technology has widen opportunities to model human conditions, including the possibility to generate bona fide human NSCs and mature neurons and consequently matching the affected cells in neurodegenerative disorders [14] .
Human hiPSC lines derived from PD patients carrying triplication of the SNCA locus have been reported [15] . These cells were proven to efficiently differentiate and mature into TH +ve dopaminergic neurons while showing a two-fold increase in aSyn protein levels with respect to hiPSCs derived from unaffected relatives and recapitulating some aspects of the patient physiology. Interestingly, neuronal precursor cells derived from these PD hiPSCs have been reported to exhibit significant deficiencies in growth, viability, cellular energy metabolism and stress resistance [16] , thus indicating that aSyn may play important roles in hNSC physiology.
Similarly, wt aSyn overexpression in fetal cortex-derived hNSCs has been shown to impair cell growth and neuronal vs glial lineage commitment [17] . Finally, aSyn overexpression has been described to reduce the number of mouse secondary neurospheres formed and to affect NSC morphology and cell cycle progression, leading to their accelerated differentiation [10] . These studies suggest that there is a link between neurogenesis, aSyn and neurodegenerative diseases [18] .
Here we report the generation of a novel in vitro cell system in which levels and timing of human wt aSyn expression can be experimentally tightly controlled in hiPSC-derived longterm expandable NSCs. Following induction, a progressive increase of aSyn levels can be achieved, leading to the formation of aSyn cytoplasmatic aggregates. This versatile system allows to investigate the effects of aSyn expression on hNSCs behaviour, including selfrenewal and differentiation programmes. Our results show that induction of aSyn leads to a reduction in hNSCs growth accompanied by an increased susceptibility to apoptosis. During neuronal differentiation process, aSyn induction affects neurogenic potential by preventing exit from self-renewal and by inducing a shift from neurogenic to gliogenic competence.
Further, acute aSyn induction resulted in enhanced apoptotic cell death in hNSC-derived dopaminergic neurons.
This novel in vitro cell system may represent a valuable tool for studying aSyn-driven pathogenic-relevant mechanisms in hNSCs and in their mature derivatives and for screening potential therapeutics.
Materials and methods

Cell cultures
AF22 cells (kindly donated by Prof. Austin Smith, Cambridge Stem Cell Institute, University of Cambridge, UK) were previously described [19] . Cells were routinely passaged every 2-3 days at a density of 2.5-3.5 x 10 4 cells/cm 2 in hNSCs Self-renewal medium composed of DMEM/F-12 (Thermo Fisher Scientific), N2 Supplement (1%, Thermo Fisher Scientific), B27
Supplement (01%, Thermo Fisher Scientific), EGF (10 ng/ml, Peprotech), bFGF (10 ng/ml, Peprotech) and Glutamax (2mM, Thermo Fisher Scientific). Briefly, before seeding the cells, plastic culture vessels were treated with 3 µg/ml Laminin (Thermo Fisher Scientific) at 37 °C for 3-5 hours. For passaging, cells were incubated for 1-2 minutes with StemPro Accutase (Thermo Fisher Scientific) and centrifuged at 260g for 3 minutes. Pellet was resuspended in fresh medium and plated onto the laminin-coated vessels.
For general neuronal differentiation, cells were seeded on laminin-coated cell culturegrade plasticware at a density of 8x10 3 cells/cm 2 in self-renewal medium. The following day, medium was shifted to self-renewal medium deprived of EGF and bFGF. After 3 additional days, medium was replaced with neuronal differentiation medium composed of a mix 1:1 of Neurobasal (Thermo Fisher Scientific), and DMEM/F-12, N2 Supplement 1%, B27 Supplement 1%, cAMP 300 ng/ml and Glutamax. For aSyn induction during differentiation process, medium supplemented with doxycycline was replaced every 24h.
For dopaminergic neuronal differentiation, self-renewing cultures were maintained in presence of 200 ng/ml of both FGF8 and SHH for 2-3 weeks to specify a ventral midbrain dopaminergic fate, prior to differentiate them as in the general neuronal differentiation. 
Cell growth assay
For growth assay, 2 x 10 3 cells/cm 2 were seeded onto laminin-coated 24-well plates.
aSyn induction was achieved by treatment with 750 ng/ml doxycycline added to the cultures and the medium was renewed every day. Cells were fixed at specific time points by using 4% paraformaldehyde for 15 minutes RT and then nuclei were stained with Hoechst 33258
(Thermo Fisher Scientific). Cell counting was performed using Operetta High-Content Imaging System (Perkin Elmer). Images were collected with a 10x long WD objective considering technical quadruplicate for each time point and the cell number was determined using the software Harmony 4.1 (Perkin Elmer) by the segmentation of the nuclear region.
Immunocytochemistry and evaluation of aSyn aggregates
For immunofluorescence assay, cells were fixed with 4% paraformaldehyde for 15 minutes at RT, then permeabilised with 0.5% Triton X-100 in PBS for 15 minutes at RT and blocked with blocking solution (5% FBS, 0.3% Triton X-100 in PBS) for 2h at room temperature.
Cultures were then incubated O/N at 4°C with specific primary antibodies (see Table S1 ) diluted in blocking solution. After three rinses with PBS, cells were incubated with the appropriate secondary antibodies (see Table S1 ) for 2 hours and nuclei counterstained with 
Western Blot analysis
Cells were lysed using the SDS sample buffer (62.5 mM Tris-HCl pH 6.8, 2% SDS, 10%
Glycerol, 50 mM DTT) and boiled for 5 minutes at 95°C before loading into a 15%
polyacrylamide gel run at 15 mA. After transfer on PVDF membrane at 100V constant for 2hrs, proteins were incubated in 0.4% paraformaldehyde in phosphate buffered saline solution for 30 min at RT as previously reported [20] and then in blocking solution (10% milk) in TBS-T for
Statistical Analysis
Statistical significance was assayed using a Student's unpaired t test or two-way ANOVA analysis of variance using the GraphPad Prism software. P < 0.05 was considered statistically significant.
Results
Modulation of wt aSyn expression in AF22 Tet-On aSyn cells
To generate a hNSC line for the inducible expression of wt aSyn, hiPSC-derived AF22 cells were infected with lentiviral particles carrying the pLVX-TetOn-Puro-human a-Syn vector.
Following infection, cultures were exposed to 1 µg/mL puromycin, chosen as optimal puromycin dose that allows for effective selection without altering the normal self-renewal potential of the resistant cells ( showed that not all of the aSyn immunoreactive cells exhibited the same levels of expression, with even a fraction of the cells that barely showed any transgene expression (Fig. 1C ).
Quantitative analysis revealed that 72.21±16.64 % of cells in culture were aSyn +ve , the remaining showing very low or undetectable aSyn immunoreactivity (Fig. 1D) (Fig. 1E) .
Longer time course analysis of doxycycline induction on AF22 Tet-On aSyn cells ( 
wt aSyn over-expression affects cell division and cell viability in AF22 Tet-On aSyn cells
To test if aSyn induction in the cultures results in phenotypic abnormalities on hNSCs growth, we performed a cell growth assay on AF22 Tet-On aSyn cells. Since aSyn has been described to influence mitochondrial activity, we decided to avoid mitochondrial activitybased growth assays. We thus performed an automated HTS cell count of stained cell nuclei on cultures fixed at defined time points.
aSyn induction produced a slight reduction in cell growth already after 72 hrs and this effect was more marked at later time-points ( Fig. 1A and Fig. 2A) , where a strong impairment in the growth occurred (% reduction in cell number: 34.12 and 44.74 at 5 and 7 days, respectively; Fig. 2A ). These data could be interpreted by possible effects elicited by aSyn either on (i) cell division, (ii) cell death, (iii) change of fate by induction of differentiation or (iv) a combination of the abovementioned effects. In order to dissect out which of these possibilities was prominent, we performed specific assays. Analysis of phospho-Histone H3 In order to test if aSyn induction could also impact on cell survival, we performed an immunofluorescent analysis for cleaved Caspase-3 at different time points following doxycycline treatment (Fig. 3A) . aSyn induction led to a marked increase in the number of apoptotic cells in culture (fold increase of cleaved Caspase-3 +ve cells in culture: 3.31, 2.03 and 2.19 at 3, 4 and 5 days, respectively) (Fig. 3B) .
On the whole, these results indicate that aSyn overexpression in hNSCs leads to a reduced cell growth by a double action, both by affecting proliferation capability and by enhancing cell death occurrence. (Fig. 4C) . Also, aSyn high cells showed an 3.1-fold increase in the parameter of area of aggregated spots with respect to aSyn mod/low cells (Fig. 4D) .
Conditional overexpression of wt
These results indicate that aSyn over-expression produces aggregation on long-term induced AF22 Tet-On aSyn cells and that the occurrence of aggregation is dependent on the level of aSyn over-expression, with aSyn high cells producing more aggregated spots with greater intensity with respect to aSyn mod/low cells. On the whole, these results indicate that there is a combined effect of aSyn overexpression in disturbing hNSC neuronal differentiation process both by decreasing the competence of the cells to respond to neuronal differentiative environment and by shifting neurogenic to gliogenic fate.
aSyn overexpression impairs neuronal differentiation in AF22 Tet
aSyn overexpression affects cell viability in AF22 Tet-On aSyn cell-derived dopaminergic neurons
AF22 cells have the competence to differentiate toward dopaminergic neuronal fate in defined in vitro conditions [19] . Thus, we next analysed the possible effects elicited by aSyn acute induction in long-term differentiated hNSC-derived dopaminergic neuronal cultures. To this aim, self-renewing AF22 Tet-On aSyn cells were patterned for three weeks with FGF8/SHH and then induced to differentiate to dopaminergic neurons for three weeks as previously reported [19, 21] 
Discussion
Although aSyn is considered of relevance for PD pathogenic process, the molecular mechanism triggering PD starting from aSyn homeostasis alteration is still a matter of debate.
Here we report the generation of a novel cellular model based on the overexpression of wt human aSyn in NSCs. The system is characterized by the controlled expression of wt human aSyn by means of a Tet-On inducible mechanism and represents a valuable tool to study the effects of aSyn overexpression in hNSCs and neurons.
The AF22 Tet-On aSyn cell model here developed has several features that make it attractive for studying the biological and molecular effects elicited by aSyn in different developmental paradigms. These include the human NSC nature of the parental AF22 cells.
Originally described by Falk and colleagues [19] , these cells have been obtained from normal human iPSCs and show features that make them ideal as parental cells to be engineered.
Indeed, they are homogeneously composed of self-renewing NSCs characterized by genomic stability and highly amenability to genetic manipulation. Importantly, these cells maintain a stable high neurogenic capability along long-term in vitro expansion and the competence to respond to specific patterning cues that allows generating defined neuronal subtype populations, including dopaminergic neurons.
The inducible nature of aSyn expression coupled to the NSC system opens to the possibility to study both acute or chronic aSyn-mediated effects in defined relevant cell populations, i.e.
neural progenitors and mature neurons. Also, this is instrumental to sort out specific effects in several processes, including self-renewing, lineage commitment and neuronal maturation and/or maintenance. systems failed to observe wt aSyn aggregates in proliferating cells [22] . This could be due to the different origin of the parental cells or to the fact that levels of aSyn induction are lower or to the quite reduced time of induction with respect to our study.
It is interesting to note that wt aSyn overexpression induces phenotypic defects in hNSCs in the self-renewing state. Other studies have reported that overexpression of aSyn in the proliferating state fails to induce any cell death in proliferating neural-like cells, despite the prominent accumulation of aSyn aggregates [12] . The factors accounting for the differential death effects could include differences in clearance mechanisms, or involvement of cell cycle molecules or other proteins differentially expressed in the two states.
An increasing number of studies reveal that aSyn may play an important role in neurogenesis. When the SNCA gene is differentially expressed or bears mutations, the in vivo NSC pool is negatively regulated and both neurogenesis and survival of newly generated neurons are decreased [9] . These studies suggest that might exist a link between neurogenesis, aSyn and neurodegenerative diseases [18] .
In vitro, aSyn overexpression has been described to reduce the number of mouse secondary neurospheres formed and to affect NSC morphology and cell cycle progression, leading to their accelerated differentiation [10] .
hiPSC-derived neuronal precursor cells from a PD patient carrying a genomic triplication of the SNCA gene showed substantial impairments in growth, viability, cellular energy metabolism and stress resistance. These effects were exacerbated when the cultures were challenged by starvation or toxic stimuli [16] . Also, overexpression of wt aSyn in expanded populations of progenitors derived from the human fetal cortex showed a slight effect on cell growth and a progressive impairment of lineage commitment competence [17] .
Similarly, studies on hESC-derived neural progenitors overexpressing wt aSyn and on neural progenitors obtained from hiPSCs fom a PD patient with a SCNA locus triplication, showed an increased cell death and reduced neurogenic capacity compared with control cultures [17, 28] .
Our results confirm that overexpression of human wt aSyn impairs the process of transition of human NSCs to neuronal cells. In particular, we have seen a major effect on the efficiency of the cells to exit from self-renewal when exposed to neuronal differentiative cues.
It
is not yet clear which molecular mechanisms trigger this specific defect. PSC-derived longterm expandable hNSCs, including the AF 22 cells, are highly responsive to efficiently undergo neuronal differentiation when exposed to the neuronal differentiative protocol here employed [19, 21] . Additional investigation is required to define if this defect is maintained when exposing the cultures to other pro-neuronal differentiative conditions. Further, exposure to non-neuronal (i.e. gliogenic) differentiation cues could help to understand if the observed refractoriness to exit self-renewal is specific for the transition toward the neuronal lineage or is a more general aSyn-mediated effect. Beside this, we have here reported a partial shift of competence of the cells from a neurogenic to a gliogenic fate, that results in increased number of astrocytes found in neuronally differentiating cultures. Other studies have reported that wt aSyn overexpression in human neural progenitors derived from fetal cortex preserved the neurogenic competence of the cells following long-term expansion [17] . To this respect, we can speculate that this discrepancy might be related to the different nature and identity between our and the abovementioned cell system. Indeed, differently from fetal brain-derived cell system that is representative of late developmental neural stages and in which the neurogenic competence quickly declines with in vitro passages, the PSC-derived hNSCs we employed are representative of earlier developmental neural stages and are extremely stable also following extensive long-term expansion [29] .
Finally, we have observed an aSyn-mediated acute toxicity in hNSC-derived neurons, being dopaminergic neurons predominantly affected. These results are in agreement with a previous study reporting acute aSyn toxicity in hESC-derived neuronal cultures [17] . These authors showed that hESC-derived neuronal cultures are highly vulnerable to expression of both wt aSyn or mutant aSyn forms, with dopaminergic neurons exhibiting higher toxic susceptibility with respect to non-dopaminergic (GABAergic) neurons. It is yet unclear the reason of this neuronal sub-types selective cytotoxicity. The factors accounting for this differential death effects in different neuronal subtypes are unknown, but could include differences in clearance mechanisms or other proteins differentially expressed in the two states. Interestingly, aSyn over-expression has been shown to directly affect TH expression, suggesting possible direct TH effects [30] . Regardless of the exact reason, this fact further validates the current model as one in which toxic effects occur preferentially in dopaminergic neurons.
In conclusion, we have developed a cell system for controlled expression of wt aSyn in hNSCs that exhibit defined aSyn-driven phenotypes both in self-renewal and differentiating/differentiated stages. This novel inducible model may prove valuable in the deciphering of aSyn-mediated pathogenic effects and in the assessment and screening of potential therapeutic strategies. 
